z-logo
Premium
Cell‐mediated immune status in patients with squamous cell carcinoma of the oral cavity
Author(s) -
Saranath Dhananjaya,
Mukhopadhyaya Rita,
Rao Rajarao S.,
Fakih Abdul R.,
Naik Sanjiv L.,
Gangal Sudha G.
Publication year - 1985
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19850901)56:5<1062::aid-cncr2820560517>3.0.co;2-6
Subject(s) - antibody dependent cell mediated cytotoxicity , immune system , medicine , lymphocyte , antibody , cancer , immunology , cytotoxicity , basal cell , carcinoma , in vitro , biology , monoclonal antibody , biochemistry
Sixteen untreated patients with squamous cell carcinoma of the oral cavity were tested for in vitro immune status in comparison with the normal healthy donors. The parameters investigated were total leukocyte and lymphocyte counts, percentages and absolute counts of T‐ and B‐cells in circulation, subsets of T‐cells identified by the Fc receptors, phytohemagglutinin (PHA), and mixed lymphocyte culture (MLC) responses, natural killer (NK) and antibody‐dependent cellular cytotoxicity (ADCC) activities, and circulating immune complexes (CICs). Eight of these patients were retested 3 to 6 months after surgery. The results showed that there was an increase in leukocyte and lymphocyte counts, an increase in the percentage and absolute number of B‐lymphocytes, an increase in the percentage of T‐gamma cells, suboptimal PHA and MLC responses, normal NK and ADCC activities, and increased levels of CICs in untreated oral cancer patients. In the postoperative stage, except for a reduction in leukocyte and lymphocyte counts, other abnormalities remained unchanged. The CICs in treated patients correlated with the tumor load in that in three patients showing recurrence, the CIC level remained elevated, whereas in patients without evidence of the disease the CIC level was either low or comparable to the upper normal limits.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here